Table 2.
Underlying disorders and predisposing conditions in patients with infective endocarditis (IE)
| |
No. (%) of patients |
|
||
|---|---|---|---|---|
| TOTAL | Native valve | Prosthetic valve | p | |
| Current IV drug use |
50 (26%) |
35 (30%) |
15 (21%) |
0.2 |
| Steroid therapy |
5 (3%) |
3 (3%) |
2 (3%) |
1 |
| Previous IE |
36 (19%) |
12 (10%) |
24 (34%) |
<0.0001 |
| Health care associated IE* |
54 (29%) |
33 (28%) |
21 (30%) |
0.3 |
| Congenital heart disease |
6 (3%) |
6 (5%) |
0 |
0.09 |
| Rheumatic heart disease |
9 (5%) |
8 (7%) |
1 (1%) |
0.2 |
| Pacemaker |
11 (6%) |
2 (2%) |
9 (13%) |
0.003 |
| Data are median [interquartile range] or numbers (%). | ||||
*Health care associated IE: chronic IV access/hemodialysis: 7/189 (4%); invasive procedures before IE (dental, urological and gastrointestinal procedures): 7/189 (4%) hospitalized in an acute care hospital before IE 38/189 (20%); resident in a nursing home or in a long-term care facility 2/189 (1%).